Primary Progressive Aphasia
What's New
Last Posted: May 15, 2024
- An autopsy case of type A FTLD-TDP with a GRN mutation presenting with the logopenic variant of primary progressive aphasia at onset and with corticobasal syndrome subsequently.
Takafumi Tomenaga, et al. Neuropathology : official journal of the Japanese Society of Neuropathology 2024 0 - Genetic Screening of Patients with Sporadic Alzheimer's Disease and Frontotemporal Lobar Degeneration in the Chinese Population.
Yaoru Li, et al. Journal of Alzheimer's disease : JAD 2024 0 - Clinical and cortical trajectories in non-fluent primary progressive aphasia and Alzheimer's disease: A role for emotion processing.
Ramon Landin-Romero, et al. Brain research 2024 0 148777 - GRN mutation spectrum and genotype-phenotype correlation in Chinese dementia patients: data from PUMCH dementia cohort.
Caiyan Liu, et al. Journal of medical genetics 2024 0 - Binary reversals: a diagnostic sign in primary progressive aphasia.
Eoin Mulroy, et al. Journal of neurology, neurosurgery, and psychiatry 2023 0 - Asymmetry of radiomics features in the white matter of patients with primary progressive aphasia.
Benedetta Tafuri, et al. Frontiers in aging neuroscience 2023 0 1120935 - Addition of the FTD Module to the Neuropsychiatric Inventory improves classification of frontotemporal dementia spectrum disorders.
Jiskoot Lize C, et al. Journal of neurology 2023 0 - C9orf72 expansions are the most common cause of genetic frontotemporal dementia in a Southeast Asian cohort.
Tan Yi Jayne, et al. Annals of clinical and translational neurology 2023 0 - Evaluating the Association Between Genetically Proxied Neurodevelopmental Language Phenotypes and the Risk for Primary Progressive Aphasia.
Nassan Malik, et al. Neurology 2023 0 - Mendelian forms of disease and age at onset affect survival in frontotemporal dementia.
Cosseddu Maura, et al. Amyotrophic lateral sclerosis & frontotemporal degeneration 2017 0 (1-2) 87-92 - Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup.
Woollacott Ione O C, et al. Alzheimer's research & therapy 2018 0 (1) 79 - Prevalence of Mathematical and Visuospatial Learning Disabilities in Patients With Posterior Cortical Atrophy.
Miller Zachary A, et al. JAMA neurology 2018 0 (6) 728-737 - Amount and delay insensitivity during intertemporal choice in three neurodegenerative diseases reflects dorsomedial prefrontal atrophy.
Beagle Alexander J, et al. Cortex; a journal devoted to the study of the nervous system and behavior 2019 0 54-65 - APOE is a correlate of phenotypic heterogeneity in Alzheimer disease in a national cohort.
Weintraub Sandra, et al. Neurology 2019 0 (6) e607-e612 - F-Flortaucipir in TDP-43 associated frontotemporal dementia.
Smith R, et al. Scientific reports 2019 0 (1) 6082 - F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes.
Tsai Richard M, et al. Alzheimer's research & therapy 2019 0 (1) 13 - C9orf72, age at onset, and ancestry help discriminate behavioral from language variants in FTLD cohorts.
Costa Beatrice, et al. Neurology 2020 0 (24) e3288-e3302 - Epilepsy in Neurodegenerative Dementias: A Clinical, Epidemiological, and EEG Study.
Arnaldi Dario, et al. Journal of Alzheimer's disease : JAD 2020 0 (3) 865-874 - In vivo staging of frontotemporal lobar degeneration TDP-43 type C pathology.
Bocchetta Martina, et al. Alzheimer's research & therapy 2020 0 (1) 34 - Functional decline in the aphasic variant of Alzheimer's disease.
Moeller Stacey, et al. Alzheimer's & dementia : the journal of the Alzheimer's Association 2021 0 (10) 1641-1648
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: